International Journal of Research in Medical Sciences,
Год журнала:
2023,
Номер
11(11), С. 4102 - 4106
Опубликована: Окт. 30, 2023
Background:
COVID-19's
recognition
as
a
multi-organ
disease
with
diverse
manifestations
extends
beyond
acute
illness
into
post-recovery
phases.
Post-COVID-19
infection,
individuals
often
endure
spectrum
of
psychiatric
symptoms,
notably
including
persistent
insomnia.
This
study
aimed
to
investigate
insomnia's
correlation
age,
gender,
comorbidity,
infection
severity,
and
biomarkers
during
hospitalization.
Methods:
employed
prospective
design
explore
the
between
insomnia
various
factors
in
COVID-19
survivors.
Data
were
collected
over
one-year
period,
an
emphasis
on
biomarkers.
Results:
The
incidence
among
patients
was
approximately
7%.
Notably,
no
significant
statistical
emerged
severity.
Furthermore,
prevalence
remained
unaffected
by
demographic
such
or
comorbidity.
Conclusions:
lasting
impact
mental
health,
particularly
terms
insomnia,
underscores
necessity
for
targeted
interventions.
Identifying
contributing
survivors
holds
paramount
importance
developing
effective
management
strategies
that
bolster
overall
well-being
quality
life.
Recognizing
addressing
long-term
consequence
becomes
imperative,
implementing
appropriate
interventions
support
services
can
mitigate
detrimental
effects
physical
health.
Ultimately,
this
contributes
improved
outcomes
enhanced
life
Asian Journal of Pharmaceutical and Clinical Research,
Год журнала:
2024,
Номер
unknown, С. 80 - 84
Опубликована: Ноя. 7, 2024
Objective:
This
is
a
retrospective
study
done
in
tertiary
care
medical
college
hospital
south
India
to
look
for
clinico-epidemiological
profile
of
coronavirus
disease
2019
(COVID-19)
patients
admitted
the
intensive
unit
(ICU).
can
help
us
identifying
risk
factors
leading
increased
mortality.
Hence,
these
modifying
treatment
depending
on
that
are
present.
Methods:
All
who
diagnosed
with
COVID-19
reverse
transcription
polymerase
chain
reaction
positivity
ICU
enrolled.
Data
collected
retrospectively
by
analyzing
case
records
and
looking
all
parameters,
such
as
age,
sex,
underlying
comorbidity,
method
oxygen
therapy,
degree
severity,
inflammatory
markers.
data
analyzed
compared
between
survivors
non-survivors.
Results:
81%
were
male
comparison
female
contributing
19%.
55%
<60
years
45%
>60
years.
Non-survivors
had
mean
age
64.5
Average
days
admission,
onset
hypoxia
after
symptom
4.2
days,
8.5
7.8
respectively.
PaO2
P/F
ratio
was
81.25
165.9,
The
average
non-survivors
144
having
187.
high-resolution
computed
tomography
score
admission
discharge
12.4
11.9,
Regarding
markers
lactate
dehydrogenase
(LDH),
Ferritin,
interleukin-6
462,
618.2,
130.56,
LDH
538.3
when
421.4.
Conclusion:
showed
there
mortality
an
increase
especially
Severe
respiratory
failure
ratio<144
Patients
Medicinski casopis,
Год журнала:
2024,
Номер
58(3), С. 83 - 93
Опубликована: Янв. 1, 2024
Objective.
The
importance
of
in
vitro
laboratory
diagnostic
tests
for
COVID-19
lies
assessing
disease
severity,
monitoring
patients,
therapeutic
monitoring,
and
predicting
prognosis.
aim
our
study
was
to
evaluate
inflammation
biomarkers
patients
their
association
with
cardiomyocyte,
liver,
kidney
damage,
impact
on
progression.
Methods.
included
50
38
(76%)
male
12
(24%)
female,
an
average
age
64.38
±
10.95
years,
treated
2021
at
the
Clinic
Infectious
Diseases
University
Clinical
Center
Kragujevac.
Biomarkers
inflammation,
damage
were
analyzed
beginning
hospitalization
tenth
day
using
standard
methods
autoanalyzer.
Results.
Analysis
showed
a
significant
increase
parameters
compared
initial
values:
leukocytes
(p=0.003),
neutrophils
(p=0.002),
platelets
(p<0.001),
C-reactive
protein
PCT
(p=0.011),
IL-6
(p=0.004).
Hepatocyte
(ALT
(p=0.005),
GGT
p=0.033)),
function
(urea
(p<0.001)
creatinine
(p=0.042))
also
increased
significantly.
Positive
correlations
found
between
cardiomyocyte
hepatocyte
admission.
CRP
concentrations
associated
risk
while
neutrophil
lymphocyte
ratio
(NLR)
platelet
(PLR)
predicted
heart
damage.
Conclusion.
Systemic
leads
disruptions
body
homeostasis,
reflected
changes
multi-system
tissue
organ
Monitoring
these
can
help
predict
progression
complications.
International Journal of Research in Medical Sciences,
Год журнала:
2023,
Номер
11(11), С. 4102 - 4106
Опубликована: Окт. 30, 2023
Background:
COVID-19's
recognition
as
a
multi-organ
disease
with
diverse
manifestations
extends
beyond
acute
illness
into
post-recovery
phases.
Post-COVID-19
infection,
individuals
often
endure
spectrum
of
psychiatric
symptoms,
notably
including
persistent
insomnia.
This
study
aimed
to
investigate
insomnia's
correlation
age,
gender,
comorbidity,
infection
severity,
and
biomarkers
during
hospitalization.
Methods:
employed
prospective
design
explore
the
between
insomnia
various
factors
in
COVID-19
survivors.
Data
were
collected
over
one-year
period,
an
emphasis
on
biomarkers.
Results:
The
incidence
among
patients
was
approximately
7%.
Notably,
no
significant
statistical
emerged
severity.
Furthermore,
prevalence
remained
unaffected
by
demographic
such
or
comorbidity.
Conclusions:
lasting
impact
mental
health,
particularly
terms
insomnia,
underscores
necessity
for
targeted
interventions.
Identifying
contributing
survivors
holds
paramount
importance
developing
effective
management
strategies
that
bolster
overall
well-being
quality
life.
Recognizing
addressing
long-term
consequence
becomes
imperative,
implementing
appropriate
interventions
support
services
can
mitigate
detrimental
effects
physical
health.
Ultimately,
this
contributes
improved
outcomes
enhanced
life
